Neil McKeganey explains how companies can make the most of a recent ruling forcing the FDA to reconsider MDOs. Read More
Tags :Centre for Substance Use Research
Recent Posts
- Weight-Loss Drugs Suppress Tobacco Cravings
- UKVIA Updates Suppliers on Changing U.K. Landscape
- Altria Reaffirms Guidance
- U.K. Misleading Public About Relative Risk: Gilchrist
- Former Researcher Sues KT&G Over E-cigarette Patents
- Diluted Diligence
- Sampoerna Profit Jumps by One Third
- EU Urged to Adopt Science-Based Strategy
- Social Media Linked to Youth Tobacco Use
- Kenya to Consult on New Health Warnings
- New President at PMFCT
- Civil Money Penalties for 22 Elfbar Sellers
- Brazil Agency Upholds Vaping Sales Ban
- Royal College Releases New E-cig Report
- NCLA Weighs in on Cigar Rules Litigation